Switzerland's news in English

Editions:  Europe · Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland

Italy seeking damages from Swiss drug giants

Share this article

A selection of €50 notes. Photo: Philippe Huguen/AFP
11:36 CEST+02:00
Italy's health ministry is seeking €1.2 billion euros ($1.6 million) in compensation from Swiss pharma giants Novartis and Roche for the manipulation of sales of a cheap drug used to treat eye problems according to Italian media reports

The ministry's move came after Italy's antitrust body fined the two firms €182.5 million over their "illicit deal to prevent the use of a very cheap drug, Avastin, in treating" sight problems.

The antitrust body said the two pharma giants had colluded with the aim of boosting the sales of a more expensive product, Lucentis. It also claimed that they steered health services and doctors away from Avastin by describing it as more dangerous.

Both Roche and Novartis market Lucentis as the best medicine for the eye disease known as macular degeneration.

Novartis has rejected the anti-competition accusations and has said it would appeal against the fine.
 

Share this article

From our sponsors

Getting a new car in Switzerland just became as easy as streaming a movie

A new car subscription rental service is shaking up the market in Switzerland with its innovative approach to accessing your vehicle. Find out about the revolution and why it may be the perfect solution for you.